41
Participants
Start Date
August 31, 2009
Primary Completion Date
December 31, 2011
Study Completion Date
March 31, 2012
Kuvan®
Brand-name Kuvan® (sapropterin) will be administered to all subjects at a dose of 20 mg/kg/day for 16 weeks.
The Children's Health Council, Palo Alto
Collaborators (1)
BioMarin Pharmaceutical
INDUSTRY
The Children's Health Council
OTHER